The JAK2V617F somatic mutation occurs in PMF and ET and almost all of PV patients, while mutations in the thrombopoietin receptor gene, MPL, and the calreticulin gene, CALR, are frequent in ET and PMF patients [7–10]. The gene discussed is MPL; the disease is acquired polycythemia vera.